With business expansion a key priority for companies globally, many are focused on identifying and entering new growth markets.
This section of International Labmate highlights successful companies establishing operations or partnerships beyond their home markets, showcasing export
To appear in our next issue, send your Business and Financial News stories to
gwyneth@intlabmate.com by Gwyneth Astles
opportunities and inspiring others to explore international business potential.
New Hyderabad office strengthens India footprint
“Our presence in India will unlock new opportunities for technology transfer, R&D collaboration, and innovation, complementing our operations across MENA and Europe.”
The Hyderabad offi ce positions EVA to better serve local health systems, integrate with international partners, and support its broader mission of advancing healthcare worldwide.
Acquisition strengthens lab informatics presence
Ribbon-cutting at EVA Holding’s new Hyderabad offi ce. Credit: EVA Holding
EVA Holding, a global leader in health and wellness, has offi cially opened a new offi ce in Hyderabad, marking a key step in the company’s expansion across Asia. The offi ce will act as a regional hub for Curium, EVA’s supply chain organisation, enhancing collaboration with international partners and supporting global supply operations.
This move follows EVA’s recent launch of its China offi ce in June 2025, underscoring the company’s strategy to strengthen supply chain infrastructure and expand its footprint in major pharmaceutical markets.
“We are expanding globally to create greater access to healthcare solutions and strengthen partnerships in key regions,” said Riad Armanious, CEO of EVA Holding.
Celebrating the launch of EVA Holding’s Hyderabad offi ce. Credit EVA Holding
More information online:
ilmt.co/PL/0Z7W 65555pr@reply-direct.com
Clinisys has acquired Orchard Software from investment fi rm Francisco Partners, combining two leaders in laboratory information systems (LIS) to offer a broader, more fl exible suite of solutions for healthcare, life sciences, and public health laboratories worldwide.
The acquisition unites Clinisys’s cloud-based LIMS and diagnostic solutions with Orchard’s proven offerings for physician offi ce, reference, and veterinary laboratories. Together, the companies aim to provide scalable, end-to- end informatics solutions that streamline lab operations and enhance patient care.
“Orchard’s mission has always been to equip laboratorians with tools for high-quality, effi cient care,” said Billie Whitehurst, Orchard CEO. “Joining Clinisys gives us the scale and innovation resources to take that mission further.”
Partnership drives advances in cell therapy manufacturing
take a minority stake in Nanotein and secure exclusive global distribution of Nanotein’s NanoSpark® activation products, including STEM-T Soluble T Cell Activator and GROW-NK Soluble Activator.
The reagents are designed to enhance T cell and natural killer (NK) cell expansion, addressing critical challenges in cell therapy production such as inconsistent yields and reliance on feeder cells. The partnership also includes joint development of new solutions for the rapidly growing cell and gene therapy markets.
“Together, we are providing cell therapy manufacturers with tools to simplify workfl ows and accelerate innovation from process development to the clinic,” said René Fáber, CEO of Sartorius Stedim Biotech.
Sartorius Stedim Biotech and Nanotein Technologies have formed a strategic partnership to advance immune cell activation and expansion for cell therapy manufacturing. As part of the collaboration, Sartorius will
Nanotein’s NanoSpark® technology uses a fully soluble protein scaffold with functional antibodies to stimulate immune cells effectively, delivering higher yields of therapeutically functional cells.
More information online:
ilmt.co/PL/1VNL 65556pr@reply-direct.com
Michael Simpson, CEO of Clinisys, added: “This acquisition strengthens our leadership in lab informatics and accelerates the development of next-generation solutions. By combining our expertise, we can better serve the full spectrum of diagnostic laboratories and support healthier, safer communities worldwide.”
Since acquiring Orchard in 2019, Francisco Partners has modernised its product suite, enhanced cloud capabilities, and strengthened leadership. The transaction brings new opportunities for growth and innovation in global lab informatics.
More information online:
ilmt.co/PL/zAjD 65557pr@reply-direct.com
Looking to grow your laboratory business internationally?
Whether you’re selling laboratory products or services and seeking new markets, or looking for local distributors and agents to represent your brand — our market-leading publication International Labmate can help you connect with the right audience.
Email:
info@intlabmate.com
Business
Opportunities
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60
